SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " BEN " 6,830 found 🔀 AI-powered Shuffle
Former Mets coach Eric Chavez slams David Stearns in rant
Former New York Mets hitting coach and bench coach Eric Chavez offered a brutal takedown of David Stearns, the team’s president of baseball operations, in an episode of “The EC3 Pod” on June 28. Stearns has come under heavy criticism…
Secret Alchemist, Sarelly and Borntostandout Are Among the Winners of The Business of Beauty Global Awards 2026
From emerging challengers to established disruptors, this year’s Global Awards winners are setting a new benchmark for beauty entrepreneurship.
Van crashes into former Benson business
A minivan drove through the side of a vacant building in Benson early Sunday morning, according to police.
Minivan crashes into vacant Benson business
WOWT 6 News 10 p.m. Sunday newscast
Flutter Entertainment plc(NYSE: FLUT) dropped from Russell 3000 Growth Benchmark
Flutter Entertainment plc dropped from Russell 3000 Growth Benchmark...
Millions take omega-3 fish oil for brain health but a new study found no benefit
Fish oil supplements successfully delivered omega-3s to the brain, but a two-year study found no meaningful benefits for memory, cognition, or Alzheimer’s-related brain changes. The results challenge the idea that fish oil pills can help prevent Alzheimer’s and shift attention toward overall diet and lifestyle instead.
Millions take omega-3 fish oil for brain health but a new study found no benefit
Fish oil supplements successfully delivered omega-3s to the brain, but a two-year study found no meaningful benefits for memory, cognition, or Alzheimer’s-related brain changes. The results challenge the idea that fish oil pills can help prevent Alzheimer’s and shift attention toward overall diet and lifestyle instead.
Why Rock Ya-Sin Is Poised to Replace Terrion Arnold
No matter what happens in court, the Lions have a major problem to solve—and Rock Ya-Sin may be the biggest beneficiary.
Stetson Bennett dealing with ‘business side’ of NFL in QB competition with Rams
Former Georgia quarterback Jake Fromm provides perspective on the challenge Stetson Bennett faces competing with Ty Simpson on the Los Angeles Rams.
Health insurers are looking for MAHA wins
The companies are offering benefits aimed at appealing to Robert F. Kennedy Jr. and his Make America Healthy Again movement.
Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Positive results from the MULBERRY Phase III trial showed that efzimfotase alfa (ALXN1850), an investigational enzyme replacement therapy, demonstrated a statistically significant and clinically meaningful improvement in bone health in children (2 to
England will miss Stokes' winning persona
Former England captain Michael Vaughan reflects on Ben Stokes' shock retirement and how the team can move on from one of their "greatest" players.
Ben Stokes announces retirement
Ben Stokes, the England captain, has stunned the cricket world by announcing his retirement in the middle of one final epic spell of bowling.
Reproduction affects health—and so does biological sex
Starting one's sex life and having children at a young age can run in the family. But can pregnancy have beneficial health effects, and do the partner's genes contribute to them? "We are just beginning ...
Jimmie Williams could be Ohio State’s most important transfer addition
After averaging more than 15 points per game at Duquesne, Jimmie Williams brings physical scoring, positional versatility, and the dependable bench offense Ohio State has lacked in recent seasons.
These tiny soil microbes could rescue crops from salty farmland
Researchers have discovered that beneficial soil bacteria give plants an unexpected survival advantage in salty soils. Instead of helping plants keep salt out, the microbes stimulate the production of lignin, a natural compound that strengthens roots and makes plants more resilient. Greenhouse and field tests showed healthier plants and higher yields in salty conditions. The findings could lead to bio-based treatments that help farmers grow crops on land once considered too salty for agriculture.
Reporter talks environmental, health impacts of mining efforts near Boundary Waters
WTIP spoke to Benji Jones, Senior Correspondent at Vox Media, about what environmental and health experts are saying about the proposed Twin Metals mining project in the Boundary Waters Watershed. Jones’ article “Mining these metals could be a boon for the climate — but there’s one big catch,” is currently available at vox.com. Below is...
Cubs Minor League Wrap: Jaxon Wiggins rehabs with South Bend
Knoxville and South Bend both win, proving again the class of the Cubs system are the middle two teams.
Trump-backed Rep. Julia Letlow wins Louisiana Senate primary runoff
Letlow defeated state Treasurer John Fleming in the GOP runoff, NBC News projects. Incumbent Sen. Bill Cassidy did not make the runoff.
PHOTOS | Multitude enjoy aerial entertainment at resurgent Texarkana Airshow
Sgt. 1st Class Benjamin Hall, assistant team leader, watches the ground to help the Golden Knights line up with their jump mark at the Texarkana Airshow on Saturday at Texarkana Regional Airport. Throngs of people lined a taxiway at the airport to watch the Army parachute team and other aerial entertainment. It was the first airshow in the city in nearly 30 years. See Monday's edition for extended coverage.
Back in business: Blue and White Snack Bar owners vow to uphold tradition of Hollidaysburg mainstay
HOLLIDAYSBURG — A local Hollidaysburg landmark is back as Blue and White Snack Bar, 905 Union St., reopened for business May 12. “The Blue and White is a landmark in Hollidaysburg and really all of Blair County. To say that people are excited to see it open again is an understatement,” Mayor Chad Repko said. […]
States seek to lower drug prices by targeting the companies that manage them for health plans
TOPEKA, Kan. — As consumers worry about medication costs, states are trying to lower drug prices by reining in big companies that oversee prescription coverage for health insurers. Some of those companies, called pharmacy benefit managers, also own pharmacies, and one of them, CVS, has spent millions of dollars fighting
GOP candidate with same name as senator can stay on Alaska ballot, judge rules
Supporters of incumbent Republican Sen. Dan Sullivan say a challenger with the same name is not running in “good faith,” but a judge says that is not an issue.
TherapyGo Announces Milestone as AI-Powered Mental Health Platform Expands Access to Licensed Psychologists
BOCA RATON, Fla., June 27, 2026 (GLOBE NEWSWIRE) -- United Innovation Solutions LLC today announced a major growth milestone for TherapyGo, its ...
The Simplest Focus Booster Is Sitting in Your Drawer Right Now
Science shows that writing by hand strengthens the brain by improving memory, focus, and deep thinking compared to typing.
Yellowstone’s supervolcano may be fueled by something unexpected
Scientists have uncovered a new explanation for what powers Yellowstone and other supervolcanoes. Instead of a deep plume rising from near Earth’s core, a broad “mantle wind” may push hot rock beneath Yellowstone, generating magma closer to the surface. This process helps create a massive underground magma network and may explain how supervolcanoes remain active for long periods.
This might be the new best smart speaker
In this week’s Installer: Gemini, Star Fox, and The Last Airbender.
How long will the Bengals’ Super Bowl window stay open?
The Bengals have Super Bowl aspirations this season.
So many colorful Samsung Galaxy Watch 9 and Galaxy Watch Ultra 2 bands leaked ahead of launch
Anyone opting for the new Galaxy Watch9 or the redesigned Galaxy Watch Ultra 2 after July 22 will be spoiled for choice. Lots and lots of watch bands in different styles and colors will be available from Samsung at launch, as roughly 60 images leaked in advance shows.
Could Israel’s coming election see an end to Netanyahu’s political career?
Israel's Prime Minister Benjamin Netanyahu faces mounting political, legal and US pressure ahead of crucial elections.
After ousting Bill Cassidy, Donald Trump faces fresh test of his sway with GOP voters in Louisiana’s Senate runoff
Louisiana Republican voters already rejected an incumbent senator who was crossways with President Donald Trump. In a primary runoff on Saturday, they’ll decide whether to follow Trump’s lead in choosing a new nominee.
CARE AT HOME GUARANTEE CORPORATION FILES PATENT APPLICATION FOR PROPRIETARY BUSINESS MANAGEMENT SYSTEM
Miami, FL, June 27, 2026 (GLOBE NEWSWIRE) -- CARE AT HOME GUARANTEE CORPORATION ('the Company'), a Florida-based Senior Care Solutions company, ...
Messi to start final Argentina group match on bench
World Cup top scorer Lionel Messi will start Argentina's final group match against Jordan on the bench, manager Lionel Scaloni confirms.
First Bend Block Party draws crowds to Central District
Live music, art, food and fun are taking over Bend’s Central District for the first Bend Block Party. Come down to Second Street near Open Space and check it out before 9 p.m. today!
Confederate flag displayed at N.C. exhibit at America's State Fair
A flag featured in the North Carolina exhibit at America’s State Fair on Washington’s National Mall is drawing some unwanted attention.
Senators call for military healthcare program to cover autism therapy as a basic benefit
A letter to Defense Secretary Pete Hegseth follows an NBC News investigation into the military healthcare program’s restrictions on applied behavioral therapy.
Democratic candidate challenging Rep. Lawler on her bid to ‘tear down political silos’
New York U.S. House candidate and combat veteran Cait Conley (D) joins Meet the Press NOW following her primary win. She faces incumbent Republican Rep. Mike Lawler in one of November’s most closely watched races as Democrats try to flip the House.
Supreme Court says Alito’s verbal reaction to Sotomayor was a ‘misunderstanding’ by Alito
The highly unusual exchange between Justice Samuel Alito and Justice Sonia Sotomayor over a dissent read from the bench was based on a “misunderstanding” by the conservative justice, the Supreme Court said Friday.
Your Social Security benefits could be cut by a quarter in 2032. Here’s what to know
Americans’ Social Security benefits will have to be cut by roughly a quarter in six years due to depleted funds, according to a June 9 report from the Social Security Board of Trustees. That’s months sooner than the group had estimated in 2025.
Walton Arts Center to host blood drive with free entertainment July 1
The Walton Arts Center will host a blood drive in partnership with the American Red Cross from 10 a.m. until 4 p.m. on Wednesday, July 1. The center will provide live entertainment for blood donors in attendance that day, including performances by cellist Carrington Truehart, and guitarists Ben Harris and William Reyes. SUBSCRIBE: Get our
State Sen. Ben Gilmore’s latest move shows politics is more chess than checkers
Politics is full of exits. Some are dramatic. Some are unexpected. And then there are the ones that remind you politics is less like a race and more like chess—
Minuteman Press Franchise Owner Dave Forster Reflects on 40 Years in Minneapolis
MINNEAPOLIS, June 26, 2026 (GLOBE NEWSWIRE) -- Dave and Sandy Forster are the owners of Minuteman Press in Minneapolis, MN since February of 198...
Two Yankees Pitching Prospects ‘Turning Heads’ in Minors This Year
The old saying is you can never have enough pitching, which the New York Yankees have apparently taken to heart. The Yankees have a stockpile of potential starting-pitching arms in the minor leagues, including Elmer Rodriguez, and two “head turning” prospects, Ben Hess and Chase Hampton. The Yankees lead the majors in team ERA (3.30) […] The post Two Yankees Pitching Prospects ‘Turning Heads’ in Minors This Year appeared first on HEAVY.
Fantasy Baseball Waiver Wire: Cooper Pratt, Jake Bennett among fresh faces to consider adding
Warren Buffett Bought A Business For $1.7B ‘Over The Phone Without Ever Meeting The People There’ Using The ‘Most Valuable Skill’ He Learned
Buying a company for $1.7 billion without meeting management sounds like the kind of decision that would keep lawyers busy for months. Warren Buffett did it over the phone. Speaking at the University of Nebraska-Lincoln in 2003, Berkshire Hathaway Chair...
Chairman Guthrie, Health Vice Chair Harshbarger, Congresswoman Miller-Meeks Lead Site Visit to Iowa Hospitals to Highlight Benefits of the Rural Health Transformation Program
The Committee on Energy and Commerce is the oldest standing legislative committee in the U.S. House of Representatives and is vested with the broadest jurisdiction of any congressional authorizing committee.
What Happens to Your Liver When You Drink Green Tea Every Day
What does green tea do for your liver? Learn how it may affect fat buildup, inflammation, and liver enzymes, plus risks and benefits.
OHSU advances massive leap in medical science with cellular therapies
Patients are benefiting from CAR-T to treat neurodegenerative diseases, cancer, lupus and other autoimmune conditions.
Ben Wood, longtime three-dot columnist known as ‘Mr. Show Business,’ dies at 94
Ben Wood, a multifaceted copy editor, food and entertainment writer, and three-dot columnist for the Honolulu Star-Bulletin and Honolulu Star-Advertiser for almost 50 years, died June 19 after several years of declining health. He was 94.
Notre Dame 2026 Player Profile: Wide Receiver Devin Fitzgerald
As the son of an NFL legend, this physical Arizona standout is already flashing elite route-running and contested-catch skills after a dominant spring debut in South Bend.
Scientists find evidence of vast hidden magma systems inside Mars
Researchers from the University of Oxford have uncovered evidence that Mars once hosted enormous, Earth-like magmatic systems deep beneath its surface—despite the planet lacking the plate tectonics long ...
Former Illinois forward Ben Humrichous signs contract with Nets
Heading to Brooklyn.
Children's Minnesota doctor warns of Benadryl challenge dangers
Heastie brushes off growing DSA influence, defeat of incumbents in Albany
Heastie sought to put the results into context while speaking with reporters at an unrelated event in Schenectady on Thursday.
Evaluating the robustness and readiness of large frontier models in health AI applications
Nature Medicine - Adversarial evaluation of leading AI models uncovers gaps between benchmark success and robustness, highlighting limitations in current health AI benchmarks and their ability to...
City council members request special meeting on planned Sports and Entertainment District
San Antonio Council Districts 1, 5 and 7 want a special meeting before Aug. 7 to guide public input on the Spurs arena’s $75M Community Benefits Agreement as the city considers a $489M Sports and Entertainment District.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Transcription by Ben Lerner wins Orwell prize for political fiction
Judging chair calls Lerner’s novel a ‘funny, brainy and timely’ study of our appetite for technology, while Karen Bartlett wins the nonfiction prize for The Escape from Kabul
That's 'Entertainment!': Q and A with Jon King of Gang of Four
Gang of Four stormed out of Leeds, England in 1976, rewiring punk rock with a Molotov cocktail of jagged guitar, danceable rhythms, and intellectual political critique. The group remains one
Crews on scene of business fire in southwest Cedar Rapids
The fire happened at Tegeler Wrecker & Crane in southwest Cedar Rapids.
From the Beginning, Politics Triggered Broadcasting
Media scholars argued that politics, not technology, shaped American broadcasting from 1927 on, repeatedly shielding incumbents from competition.
Survey finds Roy Cooper continues to hold double digit lead in N.C. Senate race
A new survey finds former North Carolina governor Roy Cooper leading former Republican National Committee Chair Michael Whatley by double digits in the pivotal Senate race in November.
Psychedelic Science 2027 Speaker Submission Invites the Field to Bridge Promise and Practice
Psychedelic Science 2027 (PS27) convenes May 3–7, 2027, at the Colorado Convention Center in Denver under the theme “Bridging Promise & Practice”PS27’s speaker submission is now open through Friday, September 18, with no planned extensionsPS27 welcomes proposals across science, therapy, policy, culture, industry, the humanities, spirituality, connected movements, and the wisdom traditions that have carried this work for generations DENVER, June 25, 2026 (GLOBE NEWSWIRE) -- The Multidisciplinary
Apolosign Digital Calendar and Portable TV for Family Organization and Home Entertainment
NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Apolosign, a smart family display brand serving more than one million households worldwide, today an...
Regenerative Agriculture and Population Health
Regenerative agriculture can enhance food quality and reduce harmful exposures through improved soil biology, biodiversity, and ecosystem health, yielding downstream benefits for agriculture, food systems, and human health. It may improve profitability through greater land resilience and lower input costs and may deliver benefits to farms, farmers, communities, and the broader environment. More research is warranted to understand the full range of potential health benefits of regenerative agriculture.
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
KUSTOM ENTERTAINMENT, INC. ANNOUNCES BINDING AGREEMENT FOR THE DIVESTITURE OF ITS VIDEO SOLUTIONS SEGMENT TO FULLY COMPLETE LIVE ENTERTAINMENT PIVOT
Transaction Structured to Provide Up to $5.5 Million plus 2,000,000 Warrants to acquire shares of common stock of Cycurion, Inc.; Follows Previously Announced Major Live Music Expansion Partnership with Gilley’s Park City OVERLAND PARK, KS, June 25, 2026 (GLOBE NEWSWIRE) -- Kustom Entertainment, Inc. (Nasdaq: KUST) (the “Company”), a live entertainment and music festival company, today announced it has entered into a binding agreement for the divestiture of its legacy video solutions division to
KUSTOM ENTERTAINMENT, INC. ANNOUNCES BINDING AGREEMENT FOR THE DIVESTITURE OF ITS VIDEO SOLUTIONS SEGMENT TO FULLY COMPLETE LIVE ENTERTAINMENT PIVOT
Transaction Structured to Provide Up to $5.5 Million plus 2,000,000 Warrants to acquire shares of common stock of Cycurion, Inc.; Follows Previously...
Athlon Sports picks Bengals to resurface an old, heartbreaking trend
Would this be enough for Zac Taylor to get another season as the Bengals head coach?
Athlon Sports picks Bengals to resurface an old, heartbreaking trend
Would this be enough for Zac Taylor to get another season as the Bengals head coach?
Looking Back on Notre Dame’s Rout of Texas in 1995
Further proof that the Texas Longhorns don’t do so well when they travel to South Bend.
Covington approves new round of small business incentives
The Covington Board of Commissioners approved a new round of small business incentives this week. Learn which businesses will benefit.
Fermented Food: Does Eating Kimchi or Sauerkraut Have Health Benefits?
Researchers are starting to understand how foods like kimchi, yogurt and sauerkraut affect our health.
Latest COVID booster may offer bonus health benefit, study suggests
The latest COVID-19 vaccine (2024-2025) has been linked to fewer serious heart-related events among U.S. veterans. New research confirmed a small reduction in COVID-related cardiovascular events, or COVID-19-associated MACE, due to the vaccine.
Mamdani's sweep in New York a 'political earthquake' among Democrats
New York City Mayor Zohran Mamdani scored a massive political victory on Tuesday when his trio of insurgent congressional candidates toppled two incumbents and the establishment favorite in an open seat, results some described as "a political earthquake" for Democrats.
Microsoft introduces cheaper Surface devices with half the memory
The 12-inch Surface Pro now starts at $849, while the 13-inch Surface Laptop costs $949 and up. Both start with 8GB of RAM instead of 16GB.
Ryman Hospitality Properties, Inc. Addresses Recent Media Reports Regarding Opry Entertainment Group
NASHVILLE, Tenn., June 24, 2026 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP) (the “Company”), a leading lodging and hospitality real estate investment trust that specializes in group-oriented, upscale convention center resorts and entertainment experiences, today addressed recent media reports regarding the Company’s Opry Entertainment Group (“OEG”) business. Colin Reed, Executive Chairman of Ryman Hospitality Properties said, “We are incredibly proud of our OEG business an
New Patient Guidebook Helps Puget Sound Beneficiaries Navigate Their Health Care
MADIGAN ARMY MEDICAL CENTER, Joint Base Lewis-McChord, Wash. -- Great news for military communities and TRICARE beneficiaries across the Pacific Northwe...
Winners and losers emerge after socialist earthquake rocks NYC primaries
Mayor Zohran Mamdani's socialist slate swept NYC Democratic primaries, defeating incumbents like Reps. Espaillat and Goldman in a major shift.
Perks of the job: Save on entertainment and essentials with BenefitHub
State of Colorado employees have access to a wide-ranging corporate discount marketplace, and those eligible for benefits at Metropolitan State University of Denver can take advantage of them with their University email. The State of Colorado BenefitHub offers deals on thousands of products, ranging from vacation and event tickets to insurance and other essential services. […]
This health data provider could benefit as AI reshapes drug research
Harvey Stober, senior equity analyst and correspondent at CNBC, explains why this healthcare company could benefit from artificial intelligence reshaping the drug industry thanks to its treasure trove of data.
Swalwell friend Gallego defends campaign-funded Super Bowl, Miami trips: ‘Go where the money is’
Sen. Ruben Gallego defends campaign-funded Super Bowl and Miami trips as legitimate fundraising efforts after scrutiny of his leadership PAC spending.
An Evening of Hope: The Center for Youth Mental Health Hosts its Annual Benefit Dinner
The annual benefit dinner for the Center for Youth Mental Health at NewYork-Presbyterian was hosted by Anna Wintour, Mariska Hargitay, Dr. Zandy Forbes, Dr. Brian G. Donley, and Kim Richter Shirley and Jon Shirley.
QED Science Launches AI Infrastructure for Scientific Validation
Recognizes The 1% After Blind Evaluation of 57,455 Scientific PreprintsTEL AVIV, Israel, June 24, 2026 (GLOBE NEWSWIRE) -- QED Science, a science validity engine and modern infrastructure for researchers, funders, institutions and life science organizations today launched The 1%, the top 574 life science preprints. The company anonymously scored 57,455 bioRxiv preprints submitted between May 2025 and April 2026 for originality and validity. The ranking is powered by QED Score, QED Science’s vali
Program Director Shares How Articulation Agreements Benefit Meredith Pre-health Post-Baccalaureate Students
Karthik Aghoram, director of Meredith’s Pre-health Post-Baccalaureate Program, recently spoke with Inspira Advantage about the program’s articulation agreements and why they are valuable for students seeking careers in health care.
Girls Flag Football is Now OHSAA’s 29th Recognized Sport
OHSAA Board of Directors voted to add girls flag football as a fully sanctioned sport
New Guidebook Helps Puget Sound Beneficiaries Navigate Their Health Care
Great news for military communities and TRICARE beneficiaries across the Pacific Northwest: navigating military healthcare just got easier. The recently released Puget Sound Patient Guidebook is a comprehensive resource designed for local TRICARE beneficiaries throughout the region. Inside, beneficiaries can find information on enrolling in the Defense Enrollment Eligibility Reporting System, understanding TRICARE plans, locating a Military Treatment Facility (MTF), scheduling appointments, accessing online services, ordering medications and much more.
QED Science Launches AI Infrastructure for Scientific Validation
QED Science Recognizes The 1% and Launches AI Infrastructure for Scientific Validation ...
Bengals News (6/24): Will Cincinnati have Patriots-like turnaround?
A favorable schedule helped the Patriots make a historic turnaround.
The new power broker: How Zohran Mamdani muscled NYC’s Democratic establishment
New York politics and the Democratic Party have a new power broker after Zohran Mamdani’s picks swept three US House primaries. Hakeem Jeffries, the Brooklyn-based House Democratic leader, is losing two incumbent members and facing an ascendant band of agitators. And the people long in charge in Democratic politics, including the ones who for decades thought of themselves as the insurgents, aren’t happy about it.
Veteran District 39 Sen. Nancy King trails political newcomer Amar Mukunda in primary election
Other Democratic incumbents with challengers appear set to return to Annapolis next year
Chevalier celebrates projected New York primary win
Democratic candidate Darializa Avila Chevalier celebrated her projected win in the Democratic primary in New York's 13th District after defeating incumbent Rep. Adriano Espaillat. Chevalier was joined by New York Mayor Zohran Mamdani who she was endorsed by.
Utah GOP Rep. Trevor Lee, known for inflammatory posts, ousted in GOP primary
Bob Stevenson beats incumbent state Rep. Trevor Lee in the Republican primary for Utah's House District 16 race.
Business owners and students alike benefit from Akron chamber’s support programs
The Greater Akron Chamber helps more than 850 small businesses in Summit and Portage counties compete with bigger businesses.
Private equity’s move into youth sports brings some truths home
Investments create benefits but also lead to higher costs and risk of inequality
Mamdani slate sweeps Democratic primaries in New York, ousts 2 incumbents from Congress
Top allies of New York Mayor Zohran Mamdani have defeated establishment-backed Democrats in New York's congressional primary elections.
Bill Ferguson wins Maryland state Senate primary after opposing Democratic redistricting plan
Incumbent Bill Ferguson defeated activist Bobby LaPin in the state legislative race in Baltimore, The Associated Press projected.
Mamdani's political gamble pays off as his endorsed candidates sweep their primaries
All three progressive candidates backed by New York Mayor Zohran Mamdani — including two who took on Democratic incumbents — won their primaries in safe seats almost guaranteeing their election in November.